Concepedia

Publication | Open Access

Phase I study of PD 0332991, a cyclin-dependent kinase inhibitor, administered in 3-week cycles (Schedule 2/1)

DOIFull Paper Access

259

Citations

17

References

2011

Year

Gary K. Schwartz, P. LoRusso, Mark A. Dickson, Sophia Randolph, M. Naveed Shaik, Keith D. Wilner, Ronan Courtney, Peter J. O’Dwyer
British Journal of Cancer

References

YearCitations

Page 1